全球乾血斑採集卡市場規模、佔有率、趨勢及成長分析報告（2026-2034年）

預計到 2025 年，乾血斑採集卡市場規模將達到 3.9563 億美元，到 2034 年將達到 6.3349 億美元，2026 年至 2034 年的複合年成長率為 5.37%。

受臨床和科研領域對便捷高效檢體採集方法的需求不斷成長的推動，幹血斑採集卡市場正經歷顯著成長。乾血斑 (DBS) 採樣具有諸多優勢，包括操作簡單、運輸成本低以及可在室溫下保存樣本。隨著就地檢驗和遠距離診斷的日益普及，DBS 技術的應用也蓬勃發展，尤其是在新生兒篩檢、傳染病檢查和治療藥物監測等領域。

此外，乾血斑（DBS）技術的進步，包括新型採集卡和分析方法的開發，提高了此採集技術的準確性和可靠性。材料和設計的創新提高了樣品穩定性，並促進了分析物的萃取，從而獲得了更準確的結果。與質譜和液相層析法等先進分析技術的結合也拓展了DBS的應用範圍，進一步推動了市場成長。

此外，診斷領域對研發的日益重視正在推動乾血斑採集卡市場的創新。製造商、醫療機構和研究機構之間的合作正在推動乾血斑技術的進步，確保新產品能夠滿足不斷變化的市場需求。人們對乾血斑採樣在提高患者依從性和檢測可及性方面的優勢認知不斷提高，也促進了該市場的擴張。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球乾血斑採集卡市場（依應用領域分類）

• 市場分析、洞察與預測
• 新生兒篩檢（NBS）
• 傳染病檢查
• 治療藥物監測
• 法醫學
• 合約研究組織/研發
• 其他

5. 全球乾血斑採集卡市場（依卡片類型分類）

• 市場分析、洞察與預測
• Whatman 903
• 阿赫爾斯特倫 226
• FTA
• 其他

6. 全球乾血斑採集卡市場依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷中心
• 其他

7. 全球乾血斑採集卡市場（依地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Hemaxis
  • Danaher Corporation
  • Shimadzu
  • PerkinElmer Inc
  • QIAGEN
  • Eastern Business Forms Inc
  • Ahlstrom
  • ARCHIMED Life Science GmbH
  • CENTOGENE NV
  • Spot On Sciences
  • Everlywell Inc
  • Neoteryx
  • Advance DX

The Dried Blood Spot Collection Cards Market size is expected to reach USD 633.49 Million in 2034 from USD 395.63 Million (2025) growing at a CAGR of 5.37% during 2026-2034.

The dried blood spot collection cards market is experiencing significant growth, driven by the increasing demand for convenient and efficient sample collection methods in clinical and research settings. Dried blood spot (DBS) sampling offers several advantages, including ease of use, reduced transportation costs, and the ability to store samples at room temperature. As the focus on point-of-care testing and remote diagnostics grows, the adoption of DBS technology is surging, particularly in applications such as newborn screening, infectious disease testing, and therapeutic drug monitoring.

Moreover, advancements in DBS technology, including the development of novel collection cards and analytical methods, are enhancing the accuracy and reliability of this sampling technique. Innovations in materials and design are improving the stability of samples and facilitating the extraction of analytes, leading to more precise results. The integration of DBS with advanced analytical techniques, such as mass spectrometry and liquid chromatography, is also expanding its applications and driving market growth.

Furthermore, the increasing focus on research and development in the field of diagnostics is fostering innovation in the dried blood spot collection cards market. Collaborations between manufacturers, healthcare providers, and research institutions are driving advancements in DBS technology, ensuring that new products meet the evolving needs of the market. The growing awareness of the benefits of DBS sampling in improving patient compliance and access to testing is also contributing to the expansion of this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• New Born Screening (NBS)
• Infectious Diseases Testing
• Therapeutic Drug Monitoring
• Forensics
• CRO/Research
• Other

By Card Type

• Whatman 903
• Ahlstrom 226
• FTA
• Others

By End Use

• Hospitals & Clinics
• Diagnostics centers
• Others

COMPANIES PROFILED

• Hemaxis, Danaher Corporation, Shimadzu, PerkinElmer Inc, QIAGEN, Eastern Business Forms Inc, Ahlstrom, ARCHIMED Life Science GmbH, CENTOGENE NV, Spot On Sciences, Everlywell Inc, Neoteryx, Advance DX

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. New Born Screening (NBS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infectious Diseases Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Therapeutic Drug Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. CRO/Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY CARD TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Card Type
• 5.2. Whatman 903 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ahlstrom 226 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. FTA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Card Type
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Card Type
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Card Type
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Card Type
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Card Type
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRIED BLOOD SPOT COLLECTION CARDS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Hemaxis
  • 9.2.2 Danaher Corporation
  • 9.2.3 Shimadzu
  • 9.2.4 PerkinElmer Inc
  • 9.2.5 QIAGEN
  • 9.2.6 Eastern Business Forms Inc
  • 9.2.7 Ahlstrom
  • 9.2.8 ARCHIMED Life Science GmbH
  • 9.2.9 CENTOGENE N.V
  • 9.2.10 Spot On Sciences
  • 9.2.11 Everlywell Inc
  • 9.2.12 Neoteryx
  • 9.2.13 Advance DX